abstract: The exchange of histones for transition proteins (TNPs) and finally protamines is an essential process during spermatogenesis that enables the strong condensation of chromatin during sperm formation. Research on this process obviously depends on the availability of specific antibodies recognizing these nuclear proteins. A commercial antibody generated against human protamine-2 (PRM2) has been described to cross-react with mouse PRM2 and in fact has been used in several studies to detect mouse PRM2. Some inconsistent results obtained with this goat-derived antibody prompted us to re-examine its specificity. In immunofluorescence experiments with epididymal sperm, only a low percentage of sperm nuclei were stained by this antibody, whereas a mouse monoclonal anti-PRM2 antibody stained most sperm, as expected. Western blot analysis of basic nuclear proteins from spermatids and sperm separated by acid urea (AU) gel electrophoresis revealed that the goat anti-PRM2 antiserum binds to mouse TNP2 but not mouse PRM2. Epitope mapping using glutathione-S-transferase-fusion proteins with peptide sequences conserved in human PRM2 and mouse TNP2 identified the tetrapeptide arginyllysyl-arginyl-threonine as an epitope of the goat anti-PRM2 antiserum. Our findings underline the importance of using AU gel electrophoresis to confirm specificities of antibodies directed against basic nuclear proteins, which are not well separated, and may show abnormal migration behaviour, in SDS-polyacrylamide gel electrophoresis.
Introduction
During sperm differentiation, histones are displaced by protamines to enable the highly condensed packing of chromatin in mature sperm (for review: Rathke et al., 2014) . Protamines are arginine-rich proteins divided into protamine-1 (PRM1) (found in all mammals) and protamine-2 (PRM2) groups (only present in some mammals, including humans, mouse and rat). Members of the latter group contain the same carboxyl-terminus and are derived from the same precursor by partial proteolysis (for review : Oliva, 2006) . Before protamines constitute the majority of chromatin basic proteins, transition proteins (TNPs) TNP1 and TNP2, which are enriched in arginine and lysine, replace most of the histones in spermatid chromatin (Rathke et al., 2014) . The functional roles of these basic nuclear proteins are not fully understood. Specific antibodies (monoclonal or polyclonal) directed against histones, TNP and protamines are essential tools to further study the functional role of these proteins. Compared with human proteins, there is only a limited number of well-performing antibodies available to specifically recognize mouse protamines and TNP. One commercial anti-PRM2 antibody (goat antiserum) generated by immunization with a peptide derived from human PRM2 is sold as an antibody specifically recognizing PRM2 from human, mouse and rat (Santa Cruz; datasheets.scbt.com/sc-23104.pdf). In several studies, this antibody was used to detect mouse PRM2 by immunofluorescence (IF) and western blotting (WB) (see, e.g. Esakky et al., 2013; Puglisi et al., 2014; Yassine et al., 2015) . We examined the specificity of this antibody, because of some unexpected results obtained with mouse sperm, and found that this antiserum in fact recognizes mouse TNP2 but not mouse PRM2. Our findings underline the necessity to confirm the specificity of antibodies when using them in another species or new application. Because nuclear basic proteins are often not well separated by SDS-polyacrylamide gel electrophoresis (PAGE), it is highly recommended to use acid urea (AU) gel electrophoresis to validate antibodies directed against these proteins.
Materials and Methods

Antibodies
The following primary antibodies were used in this study: polyclonal goat anti-PRM2 (C-14) (dilution for IF 1:200, dilution for WB 1:2000; Santa Cruz, Heidelberg, Germany, product number sc-23104, lot K0314), polyclonal goat anti-TNP2 (K-18) (IF 1:200, WB 1:1000; Santa Cruz, product number sc-21106, lot C2112), mouse monoclonal anti-PRM1 Hup1N (Stanker et al., 1987 , IF 1:400, WB 1:2000 ; Briar Patch Biosciences, Livermore, CA, USA, no product and lot number given) and mouse monoclonal anti-PRM2 Hup2B (Stanker et al., 1987 , IF 1:400, WB 1:2000 ; Briar Patch Biosciences, no product and lot number given). Secondary antibodies used were as follows: polyclonal donkey anti-goat Cy3-conjugate (1:500; Dianova, Hamburg, Germany, product number 705-165-147), polyclonal goat antimouse Alexa-Fluor 568-conjugate (1:500; Life Technologies, Darmstadt, Germany, product number A11004), polyclonal bovine anti-goat peroxidase (1:10 000; Dianova, product number 805-035-180) and polyclonal goat anti-mouse peroxidise (1:10 000; Dianova, product number 115-035-044).
IF of epididymal sperm
Epididymal sperm were released into phosphate-buffered saline (PBS) by cutting the epididymis of wild-type C57BL/6 mice into several pieces. Sperm were fixed in 4% paraformaldehyde in PBS for 2 min and washed three times with PBS, and aliquots were spotted onto glass slides and dried overnight. Sperm were permeabilized with 0.5% NP-40 in PBS for 10 min. After washing with PBS, samples were subjected to antigen retrieval in 10 mM citrate buffer (pH 6.0) at 958C for 20 min. Decondensation of chromatin was done by incubation in 10 mM DTT, 100 mM Tris-HCl (pH 8.0) at 238C for 1 h. Non-specific binding sites were blocked by incubating samples in 5% (donkey or goat) serum in PBS for at least 1 h. Slides were incubated overnight at 48C with primary antibodies (in 5% serum in PBS), washed with PBS and incubated with secondary antibodies for 1-2 h at 238C. Nuclei were stained with Hoechst dye 33342 (Sigma-Aldrich, Munich, Germany) and specimens were mounted with Prolong Gold (Life Technologies).
Western blot analysis of sperm and testis nuclear proteins
Mouse testes were homogenized in 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 2 mM EDTA and 0.5% NP-40 (Lu et al., 2010 ) using a Dounce homogenizer (tight fitting, 20 strokes, on ice) and the homogenate was centrifuged at 12 000g for 10 min (48C). The pellet was treated with 0.2 M HCl followed by centrifugation at 15 000g for 20 min (48C). The supernatant containing nuclear proteins was neutralized with 1 M Tris-HCl (pH 8.5), and proteins were separated by 15% polyacrylamide SDS -PAGE under reducing conditions and examined by WB as described (Yaghootfam et al., 2005) . Blots were stained with goat anti-PRM2 (C-14), mouse anti-PRM2 Hup2B or goat anti-TNP2 (K-18), followed by the appropriate peroxidaseconjugated secondary antibodies and enhanced chemiluminescence (ECL) detection. PageRuler prestained protein ladder (Life Technologies) served as the molecular mass marker.
Preparation of sonication-resistant spermatids and sperm
Sonication-resistant spermatid (SRS) nuclei were isolated as described by Zhao et al. (2001) with minor modifications. Mouse testes were homogenized in water containing HALT protease inhibitor mix (Life Technologies) with the help of a 1 ml-tight-fitting Dounce homogenizer (30 strokes). Homogenates were sonicated with an ultrasonic processor UP100H (Hielscher Ultrasonics GmbH, Teltow, Germany) six times for 30 s (power: 100 W) on ice, with 20 s breaks. The homogenate was then diluted with nine volumes of 83.5% (w/v) sucrose, layered on top of an 83.5% sucrose cushion and centrifuged for 1 h at 125 000g max (SW41 rotor, 27 000 rpm, 48C). The nuclear pellet was washed twice with 5 mM sodium phosphate (pH 6.5), 5 mM MgCl 2 and finally resuspended in water.
Sperm were isolated by cutting the epididymis in several pieces in Hank's buffered salt solution with a swim-out of sperm for 5 min at 378C. Sperm were pelleted by centrifugation and nuclear proteins were isolated as described below.
Extraction of basic nuclear proteins
For AU gel electrophoresis, nuclear proteins from testes extracted with HCl (see above) were precipitated with 25% trichloroacetic acid (TCA). To isolate nuclear proteins from SRSs, nuclei were resuspended in water, containing 10 mM DTT and HALT protease inhibitor mix (Life Technologies) for 30 min at 238C. After addition of one volume of 1 M HCl, samples were incubated for 15 min at 378C, followed by centrifugation at 15 000g (10 min, 48C). Nuclear proteins in the supernatant were precipitated by adding TCA to a final concentration of 25%. Basic nuclear proteins from epididymal sperm were extracted as described by de Yebra and Oliva (1993) and precipitated with 25% TCA.
AU-PAGE and western blot analysis
Nuclear extracts precipitated with 25% TCA (see above) were washed twice with acetone containing 1% of 2-mercaptoethanol, dried, dissolved in freshly prepared sample buffer (6 M urea, 0.9 M acetic acid, 10% 2-mercaptoethanol and 0.01% pyronin Y) and incubated for 45 min at 378C. Samples were separated in 18% polyacrylamide AU gels (Yu et al., 2000; Shechter et al., 2007) and stained with colloidal Coomassie Brilliant Blue G-250 (Kang et al., 2002) or transferred onto polyvinylidene difluoride (PVDF) membranes (Merck Millipore, Darmstadt, Germany) by wet electroblotting in 0.7% acetic acid (340 mA, 25 min). Membranes were stained with 0.2% Ponceau S in 5% TCA, to confirm equal transfer of proteins, and non-specific binding sites were blocked with 3% non-fat dry milk in TBST [0.05% Tween-20 in 20 mM TrisHCl (pH 7.0), 150 mM NaCl]. Primary and secondary antibodies were diluted in the same blocking solution. Bound secondary antibodies were detected by ECL using Pierce ECL Western Blotting Substrate (Life Technologies) and a Fusion chemiluminescence imaging system (VWR, Erlangen, Germany).
Expression of glutathione-S-transferasefusion proteins and epitope mapping
Sequences conserved between human PRM2 and mouse TNP2 were identified by sequence alignments using Clone Manager program (Scientific & Educational Software, Morrisville, NC, USA). Peptide sequences derived from mouse TNP2 were used to design oligonucleotide adapters encoding these sequences (with codon usage optimized for expression in Escherichia coli). Three constructs (TNP-A, -B, -C) were generated. Therefore, the following oligonucleotides (Eurofins Genomics, Ebersberg, Germany) were annealed and ligated between the BamHI and EcoRI sites of pGEX-3X (GE Healthcare, Freiburg, Germany):
The resulting constructs were transformed into E. coli JM109, confirmed by sequencing, and expression of the fusion proteins was induced by IPTG using standard procedures. Bacteria were lysed in B-PER reagent (Life Technologies) and glutathione-S-transferase (GST)-fusion proteins were purified using glutathione-agarose (Life Technologies). An irrelevant GST-fusion protein expressed and purified under the same conditions in parallel was included as a negative control. Proteins were separated by SDS -PAGE and examined by WB or colloidal Coomassie staining, as described above. Nitrocellulose membranes were stained with goat anti-PRM2 (C-14), goat anti-TNP2 (K-18) or mouse anti-PRM2 (Hup2B).
Results
The goat anti-PRM2 (C-14) antibody stains only a low percentage of mouse epididymal sperm nuclei
In order to detect PRM2 in mouse sperm, epididymal sperm were decondensed by incubation with 10 mM DTT and stained with goat anti-PRM2
(C-14) antibody. In line with a recent study (Yassine et al., 2015) , this antibody gave positive staining in the sperm nuclei (Fig. 1B) . However, IF staining of mouse epididymal sperm showed that only a small percentage of sperm were stained with the goat anti-PRM2 antibody (Fig. 1A) , which was unexpected since all mature sperm should contain large amounts of protamines. Furthermore, sperm heads stained with this antibody often displayed an abnormal morphology (Fig. 1B) . In contrast, the mouse monoclonal anti-human PRM2 antibody Hup2B, which cross-reacts with PRM2 from different species (Stanker et al., 1993) , stained most sperm heads ( Fig. 1A and C) , as expected. A goat antibody against TNP2 also stained a low percentage of sperm (Fig. 1A) as expected. Because the two PRM2 antibodies used here bind to different regions of PRM2 [Hup2B binds to the N-terminal part of fully processed PRM2 (Stanker et al., 1993) and the anti-PRM2 (C-14) antibody was generated against a (C-14), goat anti-TNP2 or mouse anti-PRM2 (Hup2B). Nuclei were counterstained with Hoechst dye 33342. The primary antibodies were omitted in control slides. The small number of sperm stained with goat PRM2 (C-14) antibody (B) often displayed an abnormal morphology of the head which was bent back towards the tail (arrow), whereas normal head morphology was found in sperm stained by the Hup2B antibody (C). DIC, differential interference contrast. Scale bars: 50 mm (A), 10 mm (B, C).
Anti-human protamine-2 antibody recognizing mouse TNP2
C-terminal peptide of human PRM2 (according to the data sheet of the supplier)], differences in epitope accessibility could have potentially explained these results and therefore further experiments using western blot analyses were performed to characterize the goat anti-PRM2 antiserum in more detail.
Goat anti-PRM2 and mouse Hup2B antibodies recognize different proteins
In western blots of sperm nuclear proteins separated by SDS-PAGE, the goat anti-PRM2 (C-14) antibody gave only very weak signals and stained protein bands that differed in molecular mass from those stained with the mouse monoclonal anti-PRM2 antibody (Hup2B) ( Fig. 2A) . Stronger signals were obtained when detergent extracts and chromatin fraction from mouse testes were examined with the PRM2 (C-14) antibody (Fig. 2B) . Notably, the goat anti-TNP2 antibody stained protein bands of the same molecular mass as PRM2 (C-14). The apparent molecular mass of the protein stained with PRM2 (C-14) antibody in testis chromatin (20 kDa) was comparable with the 22 kDa given by the commercial supplier. The strong difference to the expected molecular mass of 14 kDa could potentially be due to abnormal migration behaviour due to the high percentage of basic Figure 3 AU gel electrophoresis and western blot analysis of basic nuclear proteins. Basic nuclear proteins isolated from testis, epididymal sperm and spermatids (SRS) and separated in 18% polyacrylamide AU gels and stained with colloidal Coomassie (A) or transferred onto PVDF membranes and stained with goat anti-TNP2, goat anti-PRM2 (C-14), mouse anti-PRM2 Hup2B or mouse anti-PRM1 Hup1N (B). Positions of the major nuclear basic proteins are indicated in (A), based on their relative migration, according to Zhao et al. (2001) (p-PRM2, PRM2 precursors) . The western blots probed with anti-TNP2, anti-PRM2 (C-14) and Hup2B were from the same gel, and the different parts of the membrane to allow direct comparison of the migration of the stained proteins. The Coomassie stained gel and the samples probed with the Hup1N antibody were run on separate gels that were processed in parallel under identical conditions. residues in the PRM2 sequence. However, the apparent molecular mass of 15 kDa for the protein recognized by the Hup2B anti-PRM2 antibody argues against this possibility.
Goat anti-PRM2 antibody recognizes mouse TNP2
Because of the above-mentioned inconsistencies, we further examined the specificity of the goat PRM2 antiserum by WB of sperm and spermatid nuclear proteins separated by AU gel electrophoresis. Nuclear proteins were isolated from SRSs [corresponding to steps 12 -16 of spermatid differentiation (Yu et al., 2000) ] and epididymal sperm. Proteins were separated in 18% polyacrylamide AU gels, stained with Coomassie Brilliant Blue (Fig. 3A) or transferred onto PVDF membranes (Fig. 3B) . Immunostaining revealed the expected results in case of the mouse monoclonal antibodies Hup2B and Hup1N (which is directed against PRM1), both staining fast migrating proteins in sperm and SRSs, and the goat anti-TNP2 antiserum, which stained a slower migrating protein only in SRSs (Fig. 3B) . The protein band stained by the goat anti-PRM2 antiserum in SRSs, however, co-migrated with TNP2, but not with PRM2. Moreover, only a very weak signal was detected in sperm chromatin. These results show that the goat anti-PRM2 (C-14) antiserum specifically recognizes mouse TNP2, but not mouse PRM2.
Epitope mapping of the goat anti-human PRM2/anti-mouse TNP2 antibody
In order to confirm and to explain the unexpected finding that an antiserum directed against human PRM2 recognizes mouse TNP2, but not mouse PRM2, we compared the amino acid sequences of mouse, rat and human PRM2 and TNP2. The sequence comparison depicted in Fig. 4A shows that two, four amino acid long amino acid sequences in the C-terminus of human PRM2 are also found within the C-terminal part of mouse (and rat) TNP2, but not in mouse (and rat) PRM2 (Fig. 4A) . Three overlapping seven amino acid long peptide sequences containing these conserved sequences were expressed as GST-fusion proteins in E. coli. The GST-fusion proteins were purified via glutathione-agarose and analysed by SDS-PAGE and WB ( Fig. 4B and C) . Two fusion proteins (A and C) containing the same conserved peptide sequence were stained with the goat anti-PRM2 (C-14) antiserum. In contrast, the GST-fusion protein B that contained the other conserved peptide sequence and an irrelevant GST-fusion protein (D) were not stained by the antiserum. From these results, we conclude that the amino acid sequence arginyl-lysylarginyl-threonine (RKRT) is the minimal sequence required for binding the goat anti-PRM2 antiserum. None of the GST-fusion proteins were recognized by the goat anti-TNP2 antibody or by the mouse monoclonal Hup2B antibody, in line with the presence of its epitope in the aminoterminal part of PRM2 (Stanker et al., 1993) . Because the sequence RKRT is not present in human TNP2 (not shown), we assume that the specificity of the PRM2 (C-14) antibody for human PRM2 is not questionable, although we did not examine this further.
Discussion
Antibodies are among the most important reagents in the life sciences. Unfortunately, they also may hamper the progress of research projects because of insufficient validation, cross-reactivity with other antigens or batch-to-batch variability (Baker, 2015) . More than 50% of commercially available antibodies may be unreliable (Baker, 2015;  and references therein). Moreover, even if an antibody was found to specifically recognize an antigen in a specific species and application, it cannot be taken for granted that a specifically stained antigen in another species is the orthologue of the former antigen. As an example, we show here that a commercial goat anti-serum generated against human PRM2, which is sold and used to specifically stain mouse PRM2 recognizes mouse TNP2. The genes for PRM1, PRM2 and TNP2 are located in one gene cluster (Engel et al., 1992) and developed by gene duplications, most likely from the PRM1 gene (Nelson and Krawetz, 1993) . Therefore, partial amino acid sequence similarities between protamines and TNP2 are not completely unexpected. Identical short basic sequences in different arginine-and lysine-rich proteins may, however, also occur by chance. Basic nuclear proteins are not well separated by SDS-PAGE and therefore it is highly recommended to confirm specificities of antibodies against those proteins by WB of AU gels. According to the data sheet of the PRM2 (C-14) antibody, its antigen in mouse testis has a molecular mass of 22 kDa in SDS-PAGE (datasheets.scbt.com/sc-23104.pdf). Taking into account the inaccuracy of different molecular mass markers, it is very likely that this protein corresponds to the 20 kDa protein stained by this antibody in our experiments. Because to our knowledge, there have been no changes in the published data sheet for this antibody, it can be concluded that all batches of this antibody recognize the same antigen. With a database search in Pubmed (using 'mouse' and 'protamine' as search terms) and the reference list given in the company's antibody data sheet, we found seven publications using the goat anti-PRM2 (C-14) antibody for studies on mouse PRM2 (Häger et al., 2005; Paz et al., 2007; Poon et al., 2009; Xu et al., 2011; Esakky et al., 2013; Puglisi et al., 2014; Yassine et al., 2015) . We conclude that in all these studies TNP2 was actually stained instead of PRM2. We did not examine to what extent the results published in these reports have to be reinterpreted. Additional publications also reported experiments performed with a Santa Cruz anti-PRM2 antibody (Fukuda et al., 2013; Shinagawa et al., 2015) . It was, however, not possible to infer from these articles which of the different anti-PRM2 antibodies sold by the company was actually used. This pointed to another important issue, namely that the product number (and lot number, especially in case of polyclonal antibodies) is an essential information that should not be omitted in publications, as discussed, for example, by Helsby et al. (2013) .
